Tomokazu Obi

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains

Takashi Nonaka, Masami Masuda‐Suzukake, Tetsuaki Arai et al. · Cell Reports · 2013 · 479 citations · Full text

Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains

Fuyuki Kametani, Tomokazu Obi, Takeo Shishido et al. · Scientific Reports · 2016 · 155 citations · Full text

Expanding the clinical phenotype of <i>SNCA</i> duplication carriers

Kenya Nishioka, Owen A. Ross, Kenji Ishii et al. · Movement Disorders · 2009 · 129 citations

In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease

Tatsuhiro Terada, Tomokazu Obi, Tomoyasu Bunai et al. · Neurology · 2020 · 105 citations